Susanna Sartori

Mrs. Susanna Sartori

Politecnico di Torino, 10129 Turin, Italy
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 July 2017 in Frontiers in Bioengineering and Biotechnology
Verified
Journal Article
Open access
SCSilvia Caddeo
Silvia Caddeo
Monica BoffitoMonica Boffito
Monica Boffito
Susanna SartoriSusanna Sartori
Susanna Sartori
In the tissue engineering (TE) paradigm, engineering and life sciences tools are combined to develop bioartificial substitutes for organs and tissues, which can in turn be applied in regenerative medicine, pharmaceutical, diagnostic, and basic research to elucidate fundamental aspects of cell functions in vivo or to identify mechanisms involved in aging processes and disease onset and progression. The complex three-dimensional (3D) microenvironment in which cells are organized in vivo allows the interaction between different cell types and between cells and the extracellular matrix (ECM), the composition of which varies as a function of the tissue, the degree of maturation and health conditions. In this context, 3D in vitro models can more realistically reproduce a tissue or organ than two-dimensional (2D) models. Moreover, they can overcome the limitations of animal models and reduce the need for in vivo tests, according to the "3Rs" guiding principles for a more ethical research. The design of 3D engineered tissue models is currently in its development stage, showing high potential in overcoming the limitations of already available models. However, many issues are still opened, concerning the identification of the optimal scaffold-forming materials, cell source and biofabrication technology, and the best cell culture conditions (biochemical and physical cues) to finely replicate the native tissue and the surrounding environment. In the near future, 3D tissue engineered models are expected to become useful tools in the preliminary testing and screening of drugs and therapies and in the investigation of the molecular mechanisms underpinning disease onset and progression. In this review, the application of TE principles to the design of in vitro 3D models will be surveyed, with a focus on the strengths and weaknesses of this emerging approach. In addition, a brief overview on the development of in vitro models of healthy and pathological bone, heart, pancreas and liver will be presented.

1 March 2019 in Materials Science and Engineering: C
Verified
Journal Article
Closed access
SCSilvia Caddeo
Silvia Caddeo
MMMonica Mattioli-Belmonte
Monica Mattioli-Belmonte
Claudio CassinoClaudio Cassino
Claudio Cassino
NBNiccoletta Barbani
Niccoletta Barbani
Manuela DicarloManuela Dicarlo
Manuela Dicarlo
Gianluca CiardelliGianluca Ciardelli
Gianluca Ciardelli

31 December 2021 in Polymers
Verified
Journal Article
Open access
PDF file
Monica BoffitoMonica Boffito
Monica Boffito
LSLucia Servello
Lucia Servello
MOMarcela Arango Ospina
Marcela Arango Ospina
SMSerena Miglietta
Serena Miglietta
MTMartina Tortorici
Martina Tortorici
Aldo R. BoccacciniAldo R. Boccaccini
Aldo R. Boccaccini
The replication method is a widely used technique to produce bioactive glass (BG) scaffolds mimicking trabecular bone. However, these scaffolds usually exhibit poor mechanical reliability and fast degradation, which can be improved by coating them with a polymer. In this work, we proposed the use of custom-made poly(urethane)s (PURs) as coating materials for 45S5 Bioglass®-based scaffolds. In detail, BG scaffolds were dip-coated with two PURs differing in their soft segment (poly(ε-caprolactone) or poly(ε-caprolactone)/poly(ethylene glycol) 70/30 w/w) (PCL-PUR and PCL/PEG-PUR) or PCL (control). PUR-coated scaffolds exhibited biocompatibility, high porosity (ca. 91%), and improved mechanical properties compared to BG scaffolds (2–3 fold higher compressive strength). Interestingly, in the case of PCL-PUR, compressive strength significantly increased by coating BG scaffolds with an amount of polymer approx. 40% lower compared to PCL/PEG-PUR- and PCL-coated scaffolds. On the other hand, PEG presence within PCL/PEG-PUR resulted in a fast decrease in mechanical reliability in an aqueous environment. PURs represent promising coating materials for BG scaffolds, with the additional pros of being ad-hoc customized in their physico-chemical properties. Moreover, PUR-based coatings exhibited high adherence to the BG surface, probably because of the formation of hydrogen bonds between PUR N-H groups and BG surface functionalities, which were not formed when PCL was used.

11 November 2024 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
AGArianna Grivet-Brancot
Arianna Grivet-Brancot
MBMarianna Buscemi
Marianna Buscemi
Gianluca CiardelliGianluca Ciardelli
Gianluca Ciardelli
SBSimona Bronco
Simona Bronco
Susanna SartoriSusanna Sartori
Susanna Sartori
Monica BoffitoMonica Boffito
Monica Boffito
Background/Objectives: Chronic skin wounds (CSWs) are a worldwide healthcare problem with relevant impacts on both patients and healthcare systems. In this context, innovative treatments are needed to improve tissue repair and patient recovery and quality of life. Cord blood platelet lysate (CB-PL) holds great promise in CSW treatment thanks to its high growth factors and signal molecule content. In this work, thermo-sensitive hydrogels based on an amphiphilic poly(ether urethane) (PEU) were developed as CB-PL carriers for CSW treatment. Methods: A Poloxamer 407®-based PEU was solubilized in aqueous medium (10 and 15% w/v) and added with CB-PL at a final concentration of 20% v/v. Hydrogels were characterized for their gelation potential, rheological properties, and swelling/dissolution behavior in a watery environment. CB-PL release was also tested, and the bioactivity of released CB-PL was evaluated through cell viability, proliferation, and migration assays. Results: PEU aqueous solutions with concentrations in the range 10–15% w/v exhibited quick (within a few minutes) sol-to-gel transition at around 30–37 °C and rheological properties modulated by the PEU concentration. Moreover, CB-PL loading within the gels did not affect the overall gel properties. Stability in aqueous media was dependent on the PEU concentration, and payload release was completed between 7 and 14 days depending on the polymer content. The CB-PL-loaded hydrogels also showed biocompatibility and released CB-PL induced keratinocyte migration and proliferation, with scratch wound recovery similar to the positive control (i.e., CB-PL alone). Conclusions: The developed hydrogels represent promising tools for CSW treatment, with tunable gelation properties and residence time and the ability to encapsulate and deliver active biomolecules with sustained and controlled kinetics.

4 March 2021 in Frontiers in Bioengineering and Biotechnology
Verified
Journal Article
Open access
PDF file
Monica BoffitoMonica Boffito
Monica Boffito
Susanna SartoriSusanna Sartori
Susanna Sartori
IRIpsita Roy
Ipsita Roy
ICIrene Carmagnola
Irene Carmagnola
VCValeria Chiono
Valeria Chiono
Editorial: Advanced Therapies for Cardiac Regeneration

28 May 2026 in Frontiers in Bioengineering and Biotechnology
Verified
Journal Article
Open access
PDF file
Monica BoffitoMonica Boffito
Monica Boffito
Susanna SartoriSusanna Sartori
Susanna Sartori
VCValeria Chiono
Valeria Chiono
ICIrene Carmagnola
Irene Carmagnola
Two research articles report on the great potential of real-time and high-resolution imaging for the functional evaluation of cardiac tissues models. These two imaging studies -one ex vivo and one in vivo -illustrate the transformative role of advanced optical technologies. From the engineered monolayer to the living myocardium, high-resolution imaging is redefining how cardiac physiology and pathology can be quantified and optimized. In detail, the work by Belzil introduces a lensless, high-speed imaging platform integrated with electrical stimulation for the evaluation and monitoring of cardiac engineered tissues (Belzil et al., 2024). The system enables label-free, quantitative assessment of contractile behavior and cellular organization in stem cell-derived cardiac monolayers. Its ability to capture structural and functional parameters makes it a valuable tool for standardizing differentiation protocols and optimizing culture conditions. Validation with human induced pluripotent stem cell (iPSC)-derived and neonatal rat cardiomyocytes confirms its robustness. This imaging approach overcomes limitations of conventional microscopy, offers high temporal resolution, and links functional monitoring with improved cardiac tissue maturation. The second original article focused on imaging techniques pioneers in vivo subcellular imaging of the beating heart (Kuo et al., 2022). By synchronizing two-photon microscopy with electrocardiographic signals, the authors enabled long-term, high-precision imaging of the contracting myocardium. They identified sarcomeric changes linked to functional impairment, providing insight into post-infarction remodeling. This platform allows real-time evaluation of nanoscale cardiac dynamics and in situ monitoring of cytoskeletal and T-tubule remodeling, highlighting the role of structural integrity in contractile function and supporting the validation of biomimetic therapies.Two articles propose tissue engineering approaches for the development of cardiovascular constructs. These works illustrate diverse strategies -from biologically seeded grafts with intrinsic regenerative capacity to structurally engineered scaffolds -aimed at emulating the physical and mechanical cues of native tissues, thereby enabling new tissue formation for cardiovascular repair. For instance, the study by Iacobazzi (Iacobazzi et al., 2024) provides preclinical evidence supporting the development of living, self-remodeling vascular conduits. Using a porcine model, the authors compared small intestinal submucosa-derived grafts seeded with Wharton's Jelly derived mesenchymal stromal cells (WJ-MSCs) versus acellular controls for main pulmonary artery replacement. Over six months, WJ-MSC-seeded grafts exhibited superior remodeling, increased elastin content, and preserved patency in absence of thrombosis or calcification. These findings suggest that WJ-MSCs can turn passive scaffolds into living tissues that grow and repair, overcoming the long-term limits of current prosthetics.The other research article investigates biofabrication strategies for engineering architecturally complex cardiac scaffolds (Ketabat et al., 2023). The authors developed alginate/gelatin constructs with optimized properties, identifying one formulation with the best balance of elasticity, swelling, and biocompatibility. A novel angular scaffold design improved cell viability and organization over traditional lattices, advancing replication of the myocardium's anisotropic and hierarchical architecture.Proper recapitulation of the native myocardial microenvironment, particularly in terms of biochemical cues, is a key factor in cardiac tissue engineering. In this collection Ruocco (Ruocco et al., 2026) investigated how extracellular matrix (ECM) proteins modulate miRcombo-mediated reprogramming of adult human cardiac fibroblasts (AHCFs). Specifically, the authors demonstrated that ECM protein composition influences miRcombo-mediated direct reprogramming of AHCFs by modulating cell behavior, cytoskeletal organization, and mechanosensitive signaling pathways. Among the tested proteins, laminin and an AHCF-produced decellularized ECM provided the most supportive microenvironment for cardiac marker expression and structural maturation, whereas fibronectin and collagen I were associated with lower reprogramming efficiency and a more proliferative phenotype.The remaining two papers highlight the necessity of reliable in vitro models for advancing fundamental research and evaluating the efficacy of new cardiac therapies. Nunez-Toldra proposed the use of living myocardial slices (LMS) as ex vivo translational models for gene therapy research (Nunez-Toldra et al., 2023). In their work, thin, viable slices of rat and human cardiac tissue were maintained under physiological sarcomere length and electrical stimulation, and the protocol for their efficient transduction using some of the most cardiotropic adeno-associated viral vectors was optimized. Furthermore, LMS derived from failing human hearts were employed to validate the translational potential of the platform. This work thus established living myocardial tissue as a physiologically relevant substrate for preclinical testing of gene-based interventions, facilitating the transition from rodent studies to human-relevant models. In the other work, Takaya investigated the role of eletromechanical cues in producing in vitro cardiac tissue models and disease simulation (Takaya et al., 2023). The authors developed BEaTS-β, an opensource electromechanical bioreactor that integrates adjustable mechanical stretch, electrical pacing, and hypoxic control to mimic pathophysiological conditions such as myocardial infarction and arrhythmia. Human iPSC-derived cardiomyocytes, fibroblasts, and endothelial cells cultured under these conditions demonstrated decreased maturation and survival, faithfully mimicking clinical outcomes. Furthermore, the open-source nature of the system...